Diana Cantero

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Integrating molecular analyses with the 2021 WHO classification of adult pilocytic astrocytomas.

Integrating molecular analyses with the 2021 WHO classification of adult pilocytic astrocytomas.

Journal: Journal of neuropathology and experimental neurology

Published: December 23, 2024

Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteria.

Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteria.

Journal: Brain communications

Published: June 23, 2024

Oligodendrogliomas: findings after classifying the same cohort using pre- and post-World Health Organization (WHO) 2021 criteria.

Oligodendrogliomas: findings after classifying the same cohort using pre- and post-World Health Organization (WHO) 2021 criteria.

Journal: Brain communications

Published: June 13, 2024

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.

Journal: Cancers

Published: September 22, 2020

TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.

TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.

Journal: Neuro-oncology advances

Published: July 10, 2020

Autosomal dominant distal myopathy with nemaline rods due to p.Glu197Asp mutation in ACTA1.

Autosomal dominant distal myopathy with nemaline rods due to p.Glu197Asp mutation in ACTA1.

Journal: Neuromuscular disorders : NMD

Published: August 23, 2018

Tumor cell vanishing with radiological changes suggesting progression in IDH-mutated diffuse astrocytoma treated only with surgery.

Tumor cell vanishing with radiological changes suggesting progression in IDH-mutated diffuse astrocytoma treated only with surgery.

Journal: Clinical neuropathology

Published: August 07, 2018

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.

Journal: Journal of neuropathology and experimental neurology

Published: July 17, 2018

Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.

Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 28, 2018

Milder forms of α-sarcoglicanopathies diagnosed in adulthood by NGS analysis.

Milder forms of α-sarcoglicanopathies diagnosed in adulthood by NGS analysis.

Journal: Journal of the neurological sciences

Published: May 24, 2018

Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma.

Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma.

Journal: Neurology

Published: December 08, 2015

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

Journal: Molecular cancer therapeutics

Published: September 02, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026